Interest of high-dose pulse corticosteroid therapy combined with methotrexate for severe alopecia areata: A retrospective case series

Dermatology

Volumn 224, Issue 4, 2012, Pages 369-373

  Droitcourt, Catherine ^a   Milpied, Brigitte ^a   Ezzedine, Khaled ^a,b   Hubiche, Thomas ^a   Belin, Emilie ^a   Akpadjan, Fabrice ^a   Taeb, Alain ^a,b   Seneschal, Julien ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Alopecia areata; Methotrexate; Methylprednisolone

Indexed keywords

METHOTREXATE; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; ALOPECIA AREATA; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HAIR GROWTH; HUMAN; MALE; MORNING DOSAGE; NAUSEA; NEUTROPENIA; PATIENT SATISFACTION; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; REVIEW; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ALOPECIA AREATA; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METHOTREXATE; METHYLPREDNISOLONE; MIDDLE AGED; PULSE THERAPY, DRUG; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864865159     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000339341     Document Type: Review

References (16)

1. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV, Meyer KC, Paus R, Jahoda CA, Amos CI, Gregersen PK, Christiano AM: Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010; 466:113-117.
2. Hunt N, McHale S: The psychological impact of alopecia. BMJ 2005; 33:951-953.
3. Matzer F, Egger JW, Kopera D: Psychosocial stress and coping in alopecia areata: a questionnaire survey and qualitative study among 45 patients. Acta Derm Venereol 2011; 91: 318-327.
4. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Saphiro J: Alopecia areata update: part II. Treatment. J Am Acad Dermatol 2010; 62: 191-202.
5. Wiseman MC, Shapiro J, MacDonald N, Lui H: Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 2001; 137:1063-1068.
6. Nakajima T, Inui S, Itami S: Pulse corticoste-roid therapy for alopecia areata: study of 139 patients. Dermatology 2007; 215:320-324.
7. Perriard-Wolfensberger J, Pasche-Koo F, Mainetti C, Labarthe MP, Salomon D, Saurat JH: Pulse of methylprednisolone in alopecia areata. Dermatology 1993; 187:282-285.
8. Friedli A, Labarthe MP, Engelhardt E, Feld-mann R, Salomon D, Saurat JH: Pulse meth-ylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients. J Am Acad Dermatol 1998; 39: 597-602.
9. Assouly P, Reygagne P, Jouanique C, et al: Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients. Ann Dermatol Venereol 2003; 130: 326-330.
10. Hubiche T, Léauté-Labrèze C, Taïeb A, Bora-levi F: Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy. Br J Dermatol 2008; 58: 1136-1137.
11. Chraibi H, Dereure O, Stoebner PE, Guilhou JJ, Guillot B: Alopecia areata and pulse meth-ylprednisolone therapy. Ann Dermatol Ve-nereol 2004; 131: 286-287.
12. Joly P: The use of methotrexate alone or in combination with low doses of oral cortico-steroids in the treatment of alopecia totalis or universalis. J Am Acad Dermatol 2006; 55: 632-636.
13. Chartaux E, Joly P: Long-term follow-up of the efficacy of methotrex at ealone or in combination with low doses of oral corticoste-roids in the treatment of alopecia areata to-talis or universalis. Ann Dermatol Venereol 2010; 137:507-513.
14. KurosawAm, Nakagawa S, Mizuashi M, Sasaki Y, KawamurAm, Saito M, Aiba S: A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology 2006; 212:361-365.
15. Tosti A, Bellavista S, Iorizzo M: Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol 2006; 55:438-441.
16. Royer M, Bodemer C, Vabres P, et al: Efficacy and tolerability of methotrexate in severe childhood alopecia areata. Br J Dermatol 2011; 165:407-410.